Organovo Inc. (ONVO)
0.60
-0.10 (-14.30%)
At close: Mar 04, 2025, 3:59 PM
0.58
-3.38%
After-hours: Mar 04, 2025, 07:59 PM EST
Organovo Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY10 |
| Revenue | 109K | 370K | 1.5M | n/a | 2.2M | 3.09M | 4.6M | 4.23M | 1.48M | 571K | 379K | 1.2M | n/a |
| Cost of Revenue | n/a | 293K | 142K | 41K | 328K | 482K | 1.03M | 956K | 18.01M | 12.92M | 7.97M | 4.34M | n/a |
| Gross Profit | 109K | 77K | 1.36M | -41K | 1.87M | 2.61M | 3.57M | 3.27M | -16.52M | -12.35M | -7.59M | -3.14M | n/a |
| Operating Income | -15.09M | -17.73M | -11.48M | -16.83M | -21.48M | -27.27M | -35.27M | -38.58M | -38.64M | -30.3M | -20.65M | -9.32M | -147.82K |
| Interest Income | 405K | 454K | 8K | 15K | 594K | 705K | 478K | 198K | 88K | 32K | 18K | 5K | n/a |
| Pretax Income | -14.67M | -17.26M | -11.45M | -16.82M | -18.71M | -26.63M | -34.8M | -38.42M | -38.57M | -30.08M | -25.85M | -43.55M | -147.82K |
| Net Income | -14.67M | -17.26M | -11.45M | -16.83M | -18.71M | -26.64M | -34.8M | -38.45M | -38.58M | -30.08M | -25.85M | -43.55M | -147.82K |
| Selling & General & Admin | 9.64M | 9.09M | 9.63M | 15.71M | 17.15M | 15.13M | 20.89M | 22.3M | 22.12M | 17.95M | 13.05M | 7.08M | 120.09K |
| Research & Development | 5.5M | 8.88M | 3.32M | 1.1M | 5.28M | 14.75M | 17.96M | 19.55M | 18.01M | 12.92M | 7.97M | 3.44M | n/a |
| Other Expenses | n/a | 128K | 28K | 15K | 909K | n/a | -12K | n/a | n/a | n/a | n/a | -9K | 120.09K |
| Operating Expenses | 15.2M | 18.1M | 12.98M | 16.83M | 23.34M | 29.88M | 38.84M | 41.85M | 40.13M | 30.87M | 21.03M | 10.52M | 120.09K |
| Interest Expense | n/a | n/a | 8K | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 13K | 1.09M | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 15.2M | 18.1M | 12.98M | 16.83M | 23.67M | 30.36M | 39.87M | 42.8M | 40.13M | 30.87M | 21.03M | 10.52M | 120.09K |
| Income Tax | 2K | 2K | 2K | 2K | 2K | 3K | 2K | 23K | 3K | -215K | 5.2M | 34.23M | 27.72K |
| Shares Outstanding (Basic) | 9.14M | 8.71M | 8.7M | 6.9M | 6.48M | 5.77M | 5.36M | 4.89M | 4.5M | 3.98M | 3.66M | 3.34M | 3.6M |
| Shares Outstanding (Diluted) | 9.14M | 8.71M | 8.7M | 6.9M | 6.48M | 5.77M | 5.36M | 4.89M | 4.62M | 3.98M | 3.66M | 2.16M | 3.6M |
| EPS (Basic) | -1.6 | -1.98 | -1.32 | -2.44 | -2.89 | -4.62 | -6.49 | -7.87 | -8.57 | -7.55 | -7.07 | -13.03 | -0.04 |
| EPS (Diluted) | -1.6 | -1.98 | -1.32 | -2.44 | -2.89 | -4.62 | -6.49 | -7.87 | -8.35 | -7.55 | -7.07 | -20.19 | -0.04 |
| EBITDA | -14.81M | -17.44M | -11.34M | -16.78M | -20.33M | -26.29M | -34M | -37.43M | -37.83M | -29.61M | -25.45M | -26M | -1.12M |
| Depreciation & Amortization | 280K | 293K | 142K | 41K | 1.14M | 983K | 1.27M | 1.15M | 815K | 472K | 387K | 195K | 2.28K |